Skip to content

In the BioHarmony Drug Report Database

Agalsidase alfa

Replagal (agalsidase alfa) is an enzyme pharmaceutical. Agalsidase alfa was first approved as Replagal on 2001-08-03. It has been approved in Europe to treat fabry disease.
Trade Name Replagal
Common Name Agalsidase alfa
Indication fabry disease
Drug Class Enzymes
Agalsidase alfa
Get full access now